Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy
Publication
, Conference
Khalatbari, D; Mruthyunjaya, P; Yang, P; Stinnett, S; Chen, J; Ashton, P; Jaffe, GJ
Published in: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
May 1, 2003
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
ISSN
0146-0404
Publication Date
May 1, 2003
Volume
44
Start / End Page
U95 / U95
Location
FT LAUDERDALE, FLORIDA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Khalatbari, D., Mruthyunjaya, P., Yang, P., Stinnett, S., Chen, J., Ashton, P., & Jaffe, G. J. (2003). Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy. In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (Vol. 44, pp. U95–U95). FT LAUDERDALE, FLORIDA: ASSOC RESEARCH VISION OPHTHALMOLOGY INC.
Khalatbari, D., P. Mruthyunjaya, P. Yang, S. Stinnett, J. Chen, P. Ashton, and G. J. Jaffe. “Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy.” In INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 44:U95–U95. ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2003.
Khalatbari D, Mruthyunjaya P, Yang P, Stinnett S, Chen J, Ashton P, et al. Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy. In: INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2003. p. U95–U95.
Khalatbari, D., et al. “Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy.” INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, vol. 44, ASSOC RESEARCH VISION OPHTHALMOLOGY INC, 2003, pp. U95–U95.
Khalatbari D, Mruthyunjaya P, Yang P, Stinnett S, Chen J, Ashton P, Jaffe GJ. Fluocinolone acetonide formulated with sodium hyaluronate as a sustained release drug delivery pellet in the treatment of experimental proliferative vitreoretinopathy. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE. ASSOC RESEARCH VISION OPHTHALMOLOGY INC; 2003. p. U95–U95.
Published In
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
ISSN
0146-0404
Publication Date
May 1, 2003
Volume
44
Start / End Page
U95 / U95
Location
FT LAUDERDALE, FLORIDA
Publisher
ASSOC RESEARCH VISION OPHTHALMOLOGY INC
Conference Name
Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology
Related Subject Headings
- Ophthalmology & Optometry
- 3212 Ophthalmology and optometry
- 11 Medical and Health Sciences
- 06 Biological Sciences